Anti-malarial agents platform study (Cohort B2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-malarial agents platform study (Cohort B2), covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2) [Phase 2]